ATE212839T1 - Hämoregulatorische verbindungen - Google Patents

Hämoregulatorische verbindungen

Info

Publication number
ATE212839T1
ATE212839T1 AT96940390T AT96940390T ATE212839T1 AT E212839 T1 ATE212839 T1 AT E212839T1 AT 96940390 T AT96940390 T AT 96940390T AT 96940390 T AT96940390 T AT 96940390T AT E212839 T1 ATE212839 T1 AT E212839T1
Authority
AT
Austria
Prior art keywords
hemoregulatory
compounds
hemoregulatory compounds
fungal
viral
Prior art date
Application number
AT96940390T
Other languages
English (en)
Inventor
Pradip Kumar Bhatnagar
Michael Hartmann
Johann Hiebl
Peter Kremminger
Franz Rovenszky
James Francis Callahan
Dirk Andres Heerding
Original Assignee
Smithkline Beecham Corp
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Nycomed Austria Gmbh filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE212839T1 publication Critical patent/ATE212839T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
  • Microwave Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96940390T 1995-11-13 1996-11-12 Hämoregulatorische verbindungen ATE212839T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US657195P 1995-11-13 1995-11-13
US657395P 1995-11-13 1995-11-13
PCT/US1996/018126 WO1997017964A1 (en) 1995-11-13 1996-11-12 Hemoregulatory compounds

Publications (1)

Publication Number Publication Date
ATE212839T1 true ATE212839T1 (de) 2002-02-15

Family

ID=26675804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940390T ATE212839T1 (de) 1995-11-13 1996-11-12 Hämoregulatorische verbindungen

Country Status (15)

Country Link
EP (1) EP0861077B1 (de)
JP (1) JP2000500751A (de)
KR (1) KR19990067506A (de)
CN (1) CN1209061A (de)
AT (1) ATE212839T1 (de)
AU (1) AU711239B2 (de)
BR (1) BR9611520A (de)
CZ (1) CZ147098A3 (de)
DE (1) DE69619123D1 (de)
IL (1) IL124354A0 (de)
NO (1) NO310656B1 (de)
NZ (1) NZ323207A (de)
PL (1) PL326631A1 (de)
TR (1) TR199800850T2 (de)
WO (1) WO1997017964A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997017968A1 (en) * 1995-11-13 1997-05-22 Smithkline Beecham Corporation Hemoregulatory compounds
DK1008380T3 (da) * 1998-12-07 2004-07-12 Dsm Ip Assets Bv Fremgangsmåde og indretning til blanding eller dispergering af væsker

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917626A (en) * 1971-03-29 1975-11-04 Ici Ltd 3,6-Dioxa-1,8-octandiamido bis (pyridinium) compounds
FI77875C (fi) * 1982-11-26 1989-05-10 Nyegaard & Co As Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptider.
US4544661A (en) * 1983-09-23 1985-10-01 Chevron Research Company Fungicidal N-pyridyloxy alkyl amines
JPH0381222A (ja) * 1989-08-22 1991-04-05 Yoshitomi Pharmaceut Ind Ltd 制癌剤
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
JPH09504266A (ja) * 1993-05-24 1997-04-28 スミスクライン・ビーチャム・コーポレイション 血液調節ペプチド

Also Published As

Publication number Publication date
BR9611520A (pt) 1999-12-28
NO982151L (no) 1998-07-03
NO310656B1 (no) 2001-08-06
DE69619123D1 (de) 2002-03-21
EP0861077A4 (de) 1999-03-03
CZ147098A3 (cs) 1999-02-17
JP2000500751A (ja) 2000-01-25
WO1997017964A1 (en) 1997-05-22
CN1209061A (zh) 1999-02-24
AU7728296A (en) 1997-06-05
EP0861077B1 (de) 2002-02-06
AU711239B2 (en) 1999-10-07
PL326631A1 (en) 1998-10-12
NZ323207A (en) 1999-11-29
NO982151D0 (no) 1998-05-12
KR19990067506A (ko) 1999-08-25
EP0861077A1 (de) 1998-09-02
TR199800850T2 (xx) 1998-09-21
IL124354A0 (en) 1998-12-06

Similar Documents

Publication Publication Date Title
ES2135062T3 (es) Pirazolo y pirrolopiridinas.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
ES2159287T3 (es) Peptidos hemorreguladores.
ATE212839T1 (de) Hämoregulatorische verbindungen
DE69514928D1 (de) Gegen protozoen wirksamezyklische tetrapeptide
AU6722498A (en) Disubstituted biphenyloxazolines
BR9611904A (pt) Dioxidos de ditiazol
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties